| Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration KR Thomas, KJ Bangen, AJ Weigand, EC Edmonds, CG Wong, S Cooper, ... Neurology 94 (4), e397-e406, 2020 | 142 | 2020 |
| Early versus late MCI: Improved MCI staging using a neuropsychological approach EC Edmonds, CR McDonald, A Marshall, KR Thomas, J Eppig, ... Alzheimer's & Dementia 15 (5), 699-708, 2019 | 128 | 2019 |
| Reduced regional cerebral blood flow relates to poorer cognition in older adults with type 2 diabetes KJ Bangen, ML Werhane, AJ Weigand, EC Edmonds, L Delano-Wood, ... Frontiers in aging neuroscience 10, 270, 2018 | 124 | 2018 |
| Increasing inaccuracy of self-reported subjective cognitive complaints over 24 months in empirically derived subtypes of mild cognitive impairment EC Edmonds, AJ Weigand, KR Thomas, J Eppig, L Delano-Wood, ... Journal of the International Neuropsychological Society 24 (8), 842-853, 2018 | 77 | 2018 |
| Is tau in the absence of amyloid on the Alzheimer’s continuum?: A study of discordant PET positivity AJ Weigand, KJ Bangen, KR Thomas, L Delano-Wood, PE Gilbert, ... Brain communications 2 (1), fcz046, 2020 | 75 | 2020 |
| Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults. KJ Bangen, AJ Weigand, KR Thomas, L Delano-Wood, LR Clark, J Eppig, ... Neuropsychology 33 (5), 599, 2019 | 62 | 2019 |
| MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative KR Thomas, EC Edmonds, JS Eppig, CG Wong, AJ Weigand, KJ Bangen, ... Alzheimer's & Dementia 15 (10), 1322-1332, 2019 | 59 | 2019 |
| Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline KR Thomas, JR Osuna, AJ Weigand, EC Edmonds, AL Clark, S Holmqvist, ... Journal of Cerebral Blood Flow & Metabolism 41 (5), 1001-1012, 2021 | 56 | 2021 |
| Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults AJ Weigand, MW Bondi, KR Thomas, NL Campbell, DR Galasko, ... Neurology 95 (16), e2295-e2304, 2020 | 55 | 2020 |
| APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia AJ Weigand, KR Thomas, KJ Bangen, GML Eglit, L Delano‐Wood, ... Alzheimer's & Dementia 17 (1), 61-69, 2021 | 51 | 2021 |
| The first letter position effect in visual word recognition: The role of spatial attention. AJ Aschenbrenner, DA Balota, AJ Weigand, M Scaltritti, D Besner Journal of Experimental Psychology: Human Perception and Performance 43 (4), 700, 2017 | 50 | 2017 |
| Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes EC Edmonds, AJ Weigand, SN Hatton, AJ Marshall, KR Thomas, ... Neurology 94 (24), e2532-e2544, 2020 | 48 | 2020 |
| Parkinson disease clinical subtypes: key features & clinical milestones MC Campbell, PS Myers, AJ Weigand, ER Foster, NJ Cairns, JJ Jackson, ... Annals of clinical and translational neurology 7 (8), 1272-1283, 2020 | 47 | 2020 |
| Prediabetes is associated with brain hypometabolism and cognitive decline in a sex-dependent manner: a longitudinal study of nondemented older adults EE Sundermann, KR Thomas, KJ Bangen, AJ Weigand, JS Eppig, ... Frontiers in neurology 12, 551975, 2021 | 39 | 2021 |
| Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative KR Thomas, JS Eppig, AJ Weigand, EC Edmonds, CG Wong, AJ Jak, ... Alzheimer's & Dementia 15 (4), 561-569, 2019 | 37 | 2019 |
| Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning KJ Bangen, KR Thomas, AJ Weigand, DL Sanchez, L Delano-Wood, ... Neurobiology of aging 86, 134-142, 2020 | 36 | 2020 |
| Neuropsychological criteria for mild cognitive impairment in the Framingham Heart Study’s old-old CG Wong, KR Thomas, EC Edmonds, AJ Weigand, KJ Bangen, JS Eppig, ... Dementia and Geriatric Cognitive Disorders 46 (5-6), 253-265, 2019 | 36 | 2019 |
| Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART AJ Ehrenberg, MA Kelberman, KY Liu, MJ Dahl, D Weinshenker, N Falgàs, ... Alzheimer's & Dementia 19 (5), 2182-2196, 2023 | 34 | 2023 |
| Type 2 diabetes interacts with Alzheimer disease risk factors to predict functional decline KR Thomas, KJ Bangen, AJ Weigand, EC Edmonds, E Sundermann, ... Alzheimer Disease & Associated Disorders 34 (1), 10-17, 2020 | 34 | 2020 |
| What’s the cut-point?: a systematic investigation of tau PET thresholding methods AJ Weigand, A Maass, GL Eglit, MW Bondi Alzheimer's research & therapy 14 (1), 49, 2022 | 33 | 2022 |
